History Johnson & Johnson has been at the forefront of innovation and technological excellence for more than a century. The history of McNeil Products Limited begins in the UK in 1983 when Janssen Pharmaceutical Limited formed the Janssen Pharmacy Healthcare. Janssen Pharmacy Healthcare was formed following the switch of loperamide from POM to P and the introduction of Imodium™. During the 1980s, Janssen Pharmacy Healthcare switched more medicines from POM to P than any other OTC company and in addition to Imodium™, launched a number of brands including Stugeron™, Daktarin™, and Ovex™. In 1995 Janssen Pharmacy Healthcare merged with Centra Health Care, a 50/50 joint venture company owned by Johnson & Johnson and Merck, Sharpe and Dohme. The Centra Health Care joint venture company was renamed Johnson & Johnson.MSD Consumer Pharmaceuticals in 1996 with a key focus to capitalise on the growing trend for switching prescription only medicines to pharmacy sale. In total McNeil Products Limited and its predecessors have now switched 12 medicines from prescription only to OTC, more than any other company. We shall continue to seek to develop new and innovative solutions and services to better meet consumer healthcare needs. Zocor®, (simvastatin) is one of a group of medicines known as statins that are widely prescribed by doctors throughout the world to reduce the risk of coronary heart disease. Zocor® (simvastatin) was researched and developed by Merck Inc. In July 2004 McNeil became the first company in the world to switch a statin from prescription only to pharmacy sale. Zocor Heart-Pro® 10mg tablets are the latest addition to the wide portfolio of healthcare brands available from McNeil Products Limited and represent a paradigm shift in the type of product that can be accessed by a consumer via a pharmacy.